Metraipolis › archive › dc_e1dd35ff4251
Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in Melanoma — Europe PMC PMID:41901593
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41901593
- DOI
- 10.3390/medicina62030510
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T21:35:52.872Z
- SHA-256 of the archived text
8aab5c6743cf7fcc778974ec42ad511bc35d6741291b3ea3641fdabd43f34e1c- Stable URL of this page
https://metraipolis.com/documento/dc_e1dd35ff4251
How to cite
Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in Melanoma — Europe PMC PMID:41901593 — Europe PMC (en), https://europepmc.org/article/MED/41901593 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e1dd35ff4251 (Metraipolis archive dc_e1dd35ff4251, sha256 8aab5c6743cf7fcc778974ec42ad511bc35d6741291b3ea3641fdabd43f34e1c)
BibTeX
@misc{dce1dd35ff4251,
title = {Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in Melanoma — Europe PMC PMID:41901593},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41901593},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e1dd35ff4251; sha256 8aab5c6743cf7fcc778974ec42ad511bc35d6741291b3ea3641fdabd43f34e1c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41901593. Agents can read the archived copy with the MCP tool read_document.